BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review

Bulletin Express

Oct 22

BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).

Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1165894783"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1165894783\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1165894783?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-22 18:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165894783","market":"hk","top_or_hot":-1,"title":"BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review","media":"Bulletin Express","content":"<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeOne Medicines Ltd. (06160) Announces Q3 2025 Financial Results Release Date and Audit Committee Review\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-22 18:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).</p>\n<p>Following the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1165894783","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165894783","pubTimestamp":1761130063,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"BeOne Medicines Ltd.(06160)公布2025年第三季度财务业绩发布日期和审计委员会审查","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"BeOne Medicines Ltd. (06160) has announced that unaudited financial results for the third quarter ended September 30, 2025 will be released on Thursday, November 6, 2025, after trading hours of the Hong Kong Stock Exchange. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles and the applicable rules of the U.S. Securities and Exchange Commission, will be reviewed and approved by the audit committee on the same day (Hong Kong Time).\nFollowing the announcement, a conference call with the company’s management is scheduled for 8:00 a.m. U.S. Eastern Time on November 6, 2025 (9:00 p.m. Hong Kong Time). A live webcast will be accessible via the official investor relations section of the company's website, with an archived replay also made available. Participants are advised to register at least 15 minutes in advance for timely access.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}